CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Synergy Chc Corp.  (SNYR)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Equipment & Supplies
 
 

SNYR's Revenue Year on Year Growth by Quarter and Year

Synergy Chc.'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
SNYR Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 6.73 6.22 0.01
III Quarter September - 11.57 3.18 -
II Quarter June 9.32 8.27 2.46 -
I Quarter March 10.79 8.27 1.60 -
FY   20.11 34.84 13.46 0.01

Financial Statements
Synergy Chc.'s second quarter 2017 Revenue $ 9.32 millions SNYR's Income Statement
Synergy Chc.'s second quarter 2016 Revenue $ 8.27 millions Quarterly SNYR's Income Statement
SNYR's Growth by Division See SNYR's Growth by Segment

SNYR Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 8.2 % 62100 % -
III Quarter September - 263.84 % - -
II Quarter June 12.68 % 236.18 % - -
I Quarter March 30.47 % 416.88 % - -
FY   - 158.84 % 134500 % -



SNYR Revenue Growth Comment
Synergy Chc Corp. reported Revenue increase of 12.68% year on year in the second quarter, to $ 9.32 millions, this is lower than Synergy Chc Corp.'s recent average Revenue surge of 23393.74%.

Looking into second quarter results within Medical Equipment & Supplies industry 43 other companies have achieved higher Revenue growth. While Synergy Chc Corp.' s Revenue growth of 12.68% ranks overall at the positon no. 1132 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #44
Healthcare Sector #162
Overall #1132
Revenue Y/Y Growth Statistics
High Average Low
96916.51 % 23393.74 % 8.2 %
(Dec 31 2015)   (Dec 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SNYR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SNYR's Competitors
Revenue Growth for Synergy Chc.'s Suppliers
Revenue Growth for SNYR's Customers

You may also want to know
SNYR's Annual Growth Rates SNYR's Profitability Ratios SNYR's Asset Turnover Ratio SNYR's Dividend Growth
SNYR's Roe SNYR's Valuation Ratios SNYR's Financial Strength Ratios SNYR's Dividend Payout Ratio
SNYR's Roa SNYR's Inventory Turnover Ratio SNYR's Growth Rates SNYR's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Magellan Health Inc  21.88 %$ 21.883 millions
Healthcare Services Group Inc  21.81 %$ 21.813 millions
Regeneron Pharmaceuticals Inc  21.23 %$ 21.234 millions
Alexion Pharmaceuticals Inc  21.10 %$ 21.097 millions
Juniper Pharmaceuticals Inc  20.21 %$ 20.207 millions
Ironwood Pharmaceuticals Inc  19.74 %$ 19.737 millions
Luminex Corp  19.16 %$ 19.155 millions
Invuity, Inc.  18.79 %$ 18.789 millions
General Cannabis Corp  18.76 %$ 18.757 millions
Celgene Corp  18.65 %$ 18.651 millions
Envision Healthcare Corp  18.64 %$ 18.645 millions
Inspiremd, Inc.  18.52 %$ 18.519 millions
Entellus Medical Inc  18.21 %$ 18.206 millions
Inogen Inc  17.51 %$ 17.509 millions
Impax Laboratories Inc  17.09 %$ 17.088 millions
Pra Health Sciences, Inc.  17.08 %$ 17.084 millions
Vanda Pharmaceuticals Inc.  16.73 %$ 16.728 millions
Nantkwest, Inc.  16.67 %$ 16.667 millions
Hooper Holmes Inc  16.22 %$ 16.224 millions
Wound Management Technologies, Inc.  15.50 %$ 15.499 millions
Bioanalytical Systems Inc  15.50 %$ 15.496 millions
Sucampo Pharmaceuticals, Inc.  15.29 %$ 15.293 millions
U S Physical Therapy Inc  15.28 %$ 15.284 millions
Lhc Group, Inc  15.12 %$ 15.121 millions
Spark Therapeutics, Inc.  15.10 %$ 15.102 millions
Lemaitre Vascular Inc  15.03 %$ 15.025 millions
Heska Corp  14.59 %$ 14.587 millions
Delcath Systems, Inc.  14.29 %$ 14.286 millions
Sciclone Pharmaceuticals Inc  14.18 %$ 14.180 millions
Atricure, Inc.  14.01 %$ 14.012 millions